Stock Market

Tempest Therapeutics GAAP Earnings Miss Expectations

By Bullbit Editorial · March 30, 2026

WhatTempest Therapeutics reported GAAP EPS of -$6.33, missing expectations.
WhyThe company's financial performance fell short of market forecasts.
SignalThis earnings miss may indicate underlying business challenges.
TargetInvestors will be closely watching Tempest Therapeutics' future financial guidance.
RiskThe company's stock price may be vulnerable to further declines.